Clinical Trial Update: Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma

View source ↗

Summary

This completed clinical trial evaluated serum and peritoneal levels of CEA and CA 19-9 as potential biomarkers in patients with gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Snippet

Sponsor: Bezmialem Vakif University | Conditions: Gastric Adenocarcinoma | Status: COMPLETED